Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | M/S KANISHKA PHARMACEUTICALS | 1 | ₹2.2 L |
| 2 | Schedule 2 | M/S KANISHKA PHARMACEUTICALS | 1 | ₹874.50 |
| 3 | Schedule 3 | M/S KANISHKA PHARMACEUTICALS | 1 | ₹1,828.20 |
| 4 | Schedule 4 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 1 | ₹2,340 |
| 5 | Schedule 5 | M/S KANISHKA PHARMACEUTICALS | 1 | ₹3,970.80 |
Tender Value
₹2.9 L
EMD Value
Exempted
Closing Date
19 Jun 2025, 9:00 pmClosed
Injection Mepolizumab 100 mg
Tablet Paracetamol 325 mg and Aceclofenac 50 mg
Syrup Ibuprofen 100 mg per 5 ml
Sodium chloride isotonic solution 100 ml self collapsable
Syrup Multivitamin 200 ml bottle
7859705
GEM/2025/B/6248434
Two Packet Bid
Injection Mepolizumab 100 mg
15 days
DEHRADUN
Item wise evaluation
BOQ
6 documents required · 6 mandatory
80%
Exempted
29 May 2025
29 May 2025
19 Jun 2025
Injection Mepolizumab 100 mg
Tablet Paracetamol 325 mg and Aceclofenac 50 mg
Syrup Ibuprofen 100 mg per 5 ml
Sodium chloride isotonic solution 100 ml self collapsable
Syrup Multivitamin 200 ml bottle
Injection Mepolizumab 100 mg
Tablet paracetamol 325 mg and Aceclofenac 50 mg
Syrup Ibuprofen 100 mg per 5 ml
Sodium Chloride Isotonic solution 100 ml self collapsable
Syrup Multivitamins
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7859705.pdf
GEM_BID
specif_a171bc5e-9a95-460e-9d4b1747646604412_consignee314.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
specif_2025-05-19-14-40-42_5a8b3cc4f07b053eef53340dbcdf990d.pdf
BOQ
boq_item_sample_file-1_2025-05-19-14-40-42_d944320ba0466cc42bca3f24974aa1c5.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .